Pseudoallescheria boydii pneumonia and empyema: A rare complication of heart transplantation cured with voriconazole

Journal of Heart and Lung Transplantation

Volumn 23, Issue 5, 2004, Pages 647-649

  Perlroth, Mark G ^a,c   Miller, Joan ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN; DILTIAZEM; FUROSEMIDE; GLIBENCLAMIDE; HEPARIN; HYDROCHLOROTHIAZIDE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; PRAVASTATIN; PREDNISONE; ROSIGLITAZONE; STEROID; TACROLIMUS; VORICONAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE COURSE; DRUG RESPONSE; EMPYEMA; HEART TRANSPLANTATION; HOST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MALE; NEUROTOXICITY; ORTHOTOPIC TRANSPLANTATION; PETRIELLIDIUM BOYDII; PHYSICAL EXAMINATION; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEIZURE; THROMBOCYTOPENIA; TRANSITIONAL BLINDNESS; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; EMPYEMA; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LUNG DISEASES, FUNGAL; MADUROMYCOSIS; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PSEUDALLESCHERIA; PYRIMIDINES; TRIAZOLES;

EID: 2342574689     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00298-5     Document Type: Article

References (13)

1. Kwon-Chung KJ, Bennett JE. Medical mycology. Philadelphia: Lea & Febiger, 1994:678-694
2. Berenguer J, Diaz-Mediavilla, Urra D, Munoz P. Central nervous system infection caused by Pseudoallescheria boydii: case report and review. Rev Infect Dis 1989;11:890-896
3. Bousley P.H. Isolation of Allescheria boydii from pleural fluid. J Clin Microbiol. 5:1977;244
4. Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudoallescheria boydii (Anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature 2002;81:333-48
5. Travis L.B., Roberts G.D., Wilson W.R. Clinical significance of Pseudoallescheria boydii: a review of 10 years experience. Mayo Clin Proc. 60:1985;531-537
6. Galgiani J.N., Stevens D.A., Graybill J.R., Stevens D.L., Tillinghast A.J., Levine H.B. Pseudoallescheria boydii infections treated with ketoconazole. Chest. 86:1984;219-224
7. Johnson E.M., Szekely A., Warnock D.W. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother. 42:1998;741-745
8. Winston D.J., Jordan M.C., Rhodes J. Allescheria boydii infections in the immunosuppressed host. Am J Med. 63:1977;830-835
9. Goldberg S.L., Geha D.J., Marshall W.F., Inwards D.J., Hoagland H.C. Successful treatment of simultaneous pulmonary Pseudoallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis. 16:1993;803-805
10. Anonymous. Voriconazole. Med Lett Drugs Ther 2002;44:63-5
11. Walsh T.J., Pappas P., Winston D.J., et al. Voriconazole compared with liposomal Amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 346:2002;225-234
12. Romero A.J., Le Pogamp P., Nilsson L.-G., Wood N. Effect of voriconazole on pharmacokinetics of cyclosporine in renal transplant recipients. Clin Pharmacol Ther. 71:2002;224-234
13. Venkataramanan R., Zang S., Gayowski T., Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother. 46:2002;3091-3093